Open-Angle Glaucoma (Primary) Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About Open-Angle Glaucoma (Primary)
Primary open-angle glaucoma is a leading cause of irreversible vision loss, often progressing silently. It's a chronic condition requiring ongoing treatment, which can be expensive. TheDrugClub helps individuals and families manage these costs by providing significant savings on essential medications, ensuring you can afford the care needed to protect your precious eyesight.
Primary open-angle glaucoma (POAG) is the most common form of glaucoma, a group of eye conditions that damage the optic nerve—the vital link between your eye and brain. This damage is often associated with high pressure inside your eye, known as intraocular pressure (IOP).
In POAG, the 'angle' where the iris and cornea meet, allowing fluid to drain from the eye, remains open. However, the drainage system itself isn't working as efficiently as it should. This leads to a gradual buildup of fluid, increasing the IOP, which then puts pressure on the optic nerve. Because it typically develops slowly and without noticeable symptoms in its early stages, POAG is often called the "silent thief of sight." By the time vision changes are apparent, irreversible damage may have already occurred, starting with peripheral vision loss and eventually affecting central vision if left untreated.
Common Treatments and Medications
The primary goal of glaucoma treatment is to lower IOP to prevent further optic nerve damage. This is most commonly achieved through prescription eye drops, which either decrease the production of fluid in the eye or increase its outflow. Some frequently prescribed medications include:
- Prostaglandin analogs: Such as latanoprost (Xalatan), bimatoprost (Lumigan), and travoprost (Travatan Z). These are often a first-line treatment, increasing fluid drainage.
- Beta-blockers: Like timolol (Timoptic), which reduce the production of fluid.
- Alpha-adrenergic agonists: For example, brimonidine (Alphagan P), which can both decrease fluid production and increase drainage.
- Carbonic anhydrase inhibitors: Such as dorzolamide (Trusopt), which decrease fluid production.
In some cases, oral medications, laser therapy (like Selective Laser Trabeculoplasty, or SLT), or surgical procedures (such as trabeculectomy or minimally invasive glaucoma surgeries) may be necessary if eye drops
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.